文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

多措并举预防方案对呼吸机相关性肺炎的影响:包括选择性口咽去污染

Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination.
PubMed 文献 · Intensive Care Med · 2018-10-21
一句话结论多措并举预防方案(含选择性口咽去污染)使机械通气>48小时患者的VAP发生率持续下降,干预期降低56%,后干预期降低85%。

该研究在机械通气>48小时的患者队列中,比较了8个月干预前、12个月干预期和11个月后干预期的VAP发生率。干预期实施九项预防措施(包括选择性口咽去污染SOD),主要终点为首次VAP发生,采用Cox病因特异性比例风险模型。结果显示VAP发生率从干预前24.0/1000通气日降至干预期11.0和后干预期3.9;干预期风险降低56%(HR 0.44),后干预期降低85%(HR 0.15)。实施八项措施未加SOD时VAP降低42%(HR 0.58),加用SOD后降低70%(HR 0.30)。

要点

  • 干预前、干预期、后干预期VAP发生率分别为24.0、11.0、3.9例/1000通气日。
  • 与干预前相比,干预期VAP风险降低56%(HR 0.44,95%CI 0.29-0.65,P<0.001),后干预期降低85%(HR 0.15,95%CI 0.08-0.27,P<0.001)。
  • 干预期内,实施八项预防措施(不含SOD)后VAP风险降低42%(HR 0.58,95%CI 0.38-0.87,P<0.001);加用SOD后降低70%(HR 0.30,95%CI 0.13-0.72,P<0.001)。
  • 对粘菌素或妥布霉素内在耐药细菌的 incidence density 未增加。
  • 干预前至后干预期,治疗下呼吸道感染的广谱抗生素每1000患者日使用天数显著减少(P<0.028),机械通气中位时长从7.1天降至6.4天(P<0.003),ICU死亡率从16.2%降至13.5%(P<0.049)。

适用人群与场景

  • 接受机械通气>48小时的患者队列。

处置流程与药物剂量

  • 干预方案包括九项预防措施,其中包含选择性口咽去污染(SOD)。
  • 干预期内,先实施八项预防措施(不含SOD),随后加用SOD。

研究设计与关键结果

  • 研究类型为队列研究,比较8个月干预前、12个月干预期和11个月后干预期。
  • 主要终点为首次VAP发生,采用Cox病因特异性比例风险模型分析。
  • 干预前、干预期、后干预期VAP发生率分别为24.0、11.0、3.9例/1000通气日。
  • 与干预前相比,干预期VAP风险降低56%(HR 0.44,95%CI 0.29-0.65,P<0.001),后干预期降低85%(HR 0.15,95%CI 0.08-0.27,P<0.001)。
  • 干预期内,实施八项预防措施(不含SOD)后VAP风险降低42%(HR 0.58,95%CI 0.38-0.87,P<0.001);加用SOD后降低70%(HR 0.30,95%CI 0.13-0.72,P<0.001)。
  • 对粘菌素或妥布霉素内在耐药细菌的 incidence density 未增加。
  • 干预前至后干预期,治疗下呼吸道感染的广谱抗生素每1000患者日使用天数显著减少(P<0.028),机械通气中位时长从7.1天降至6.4天(P<0.003),ICU死亡率从16.2%降至13.5%(P<0.049)。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该预防方案实现了VAP发生率的持续下降,SOD提供了附加价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: We describe the impact of a multifaceted program for decreasing ventilator-associated pneumonia (VAP) after implementing nine preventive measures, including selective oropharyngeal decontamination (SOD).

METHODS: We compared VAP rates during an 8-month pre-intervention period, a 12-month intervention period, and an 11-month post-intervention period in a cohort of patients who received mechanical ventilation (MV) for > 48 h. The primary objective was to assess the effect on first VAP occurrence, using a Cox cause-specific proportional hazards model. Secondary objectives included the impact on emergence of antimicrobial resistance, antibiotic consumption, duration of MV, and ICU mortality.

RESULTS: Pre-intervention, intervention and post-intervention VAP rates were 24.0, 11.0 and 3.9 VAP episodes per 1000 ventilation-days, respectively. VAP rates decreased by 56% [hazard ratio (HR) 0.44, 95% CI 0.29-0.65; P < 0.001] in the intervention and by 85% (HR 0.15, 95% CI 0.08-0.27; P < 0.001) in the post-intervention periods. During the intervention period, VAP rates decreased by 42% (HR 0.58, 95% CI 0.38-0.87; P < 0.001) after implementation of eight preventive measures without SOD, and by 70% after adding SOD (HR 0.30, 95% CI 0.13-0.72; P < 0.001) compared to the pre-intervention period. The incidence density of intrinsically resistant bacteria (to colistin or tobramycin) did not increase. We documented a significant reduction of days of therapy per 1000 patient-days of broad-spectrum antibiotic used to treat lower respiratory tract infection (P < 0.028), median duration of MV (from 7.1 to 6.4 days; P < 0.003) and ICU mortality (from 16.2 to 13.5%; P < 0.049) for patients ventilated > 48 h between the pre- and post-intervention periods.

CONCLUSIONS: Our preventive program produced a sustained decrease in VAP incidence. SOD provides an additive value.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Landelle C, Nocquet Boyer V, Abbas M, et al. Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination. Intensive Care Med. 2018. PMID: 30343312. doi:10.1007/s00134-018-5227-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。